Evidence map›Paper›PMID 41188743›Full record

ArticleBMC infectious diseases2025

The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in Sri Lankan children and association with the nutritional status.

Chandima Jeewandara, Maneshka Vindesh Karunananda, Suranga Fernando, Saubhagya Danasekara, Gamini Jayakody, S Arulkumaran, N Y Samaraweera, Sarathchandra Kumarawansha, Subramaniyam Sivaganesh, P Geethika Amarasinghe and 18 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Chandima Jeewandara *Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Maneshka Vindesh Karunananda *Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Suranga Fernando *Ministry of Health, Colombo, Sri Lanka.
Saubhagya DanasekaraAllergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
Gamini JayakodyMinistry of Health, Colombo, Sri Lanka.
S ArulkumaranMinistry of Health, Colombo, Sri Lanka.
N Y SamaraweeraMinistry of Health, Colombo, Sri Lanka.
Sarathchandra KumarawanshaMinistry of Health, Colombo, Sri Lanka.
Subramaniyam SivaganeshMinistry of Health, Colombo, Sri Lanka.
P Geethika AmarasingheMinistry of Health, Colombo, Sri Lanka.
Chintha JayasingheMinistry of Health, Colombo, Sri Lanka.
Dilini WijesekaraMinistry of Health, Colombo, Sri Lanka.
Manonath Bandara MarasingheMinistry of Health, Colombo, Sri Lanka.
Udari MambulageMinistry of Health, Colombo, Sri Lanka.
Helanka WijayatilakeMinistry of Health, Colombo, Sri Lanka.
Kasun SenevirathneMinistry of Health, Colombo, Sri Lanka.
A D P BandaraMinistry of Health, Colombo, Sri Lanka.
C P GallageMinistry of Health, Colombo, Sri Lanka.
N R ColambageMinistry of Health, Colombo, Sri Lanka.
A A Thilak UdayasiriMinistry of Health, Colombo, Sri Lanka.
Tharaka LokumarambageMinistry of Health, Colombo, Sri Lanka.
Y UpasenaMinistry of Health, Colombo, Sri Lanka.
W P K P WeerasooriyaMinistry of Health, Colombo, Sri Lanka.
Tiong Kit TanMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Alain TownsendMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Graham S OggMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Gathsaurie Neelika MalavigeAllergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka. gathsaurie.malavige@ndm.ox.ac.uk.
seroprevalence study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order to determine if undernutrition affects the presence, breadth and magnitude of antibodies to SARS-CoV-2 and variants, we studied SARS-CoV-2 specific antibody responses in a large island wide serosurvey in children in Sri Lanka.

methodsUsing the WHO UNITY protocol, we recruited 5207 children, aged 10 to 20 years, and assessed anthropometric measures, seropositive rates, ACE2 blocking antibodies and antibodies to omicron variants, in vaccinated and unvaccinated children.

results3111/3119 (99.7%) vaccinated and 2008/2088 (96.2%) of unvaccinated children were seropositive for SARS-CoV-2, although the detection of ACE2 blocking antibodies were significantly higher in vaccinated children (2984/3111, 95.9%) compared to unvaccinated (1346/2008, 67.0%). 1057 (22.1%) had a BMI < 3rd centile for age, and therefore were classified as underweight. Unvaccinated children, with < 3rd BMI centile had significantly lower ACE2 blocking antibodies than other groups. There were no differences in the antibody titres to XBB.1.5 or BA.2.75 based on the BMI category.

conclusionsThe high seropositivity rates, with high antibody titres to SARS-CoV-2 variants in unvaccinated children indicates possible multiple infections with SARS-CoV-2. The implications of lower antibody levels in underweight children should be further investigated.

Indexed as

Antibodies, ViralCOVID-19Nutritional StatusSARS-CoV-2AdolescentChildCOVID-19 VaccinesCross ReactionsFemaleHumansMaleSeroepidemiologic StudiesSri LankaUnvaccinated PersonsYoung AdultAntibodies, ViralCOVID-19 VaccinesACE2 blocking antibodiesAntibodiesBody mass indexSARS-CoV-2SeroprevalenceVariants

Identifiers

PMID41188743
PMCPMC12584496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.